Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes

Journal of Diabetes and its Complications

Volumn 30, Issue 6, 2016, Pages 1074-1080

  Zhao, Cui Chun ^a   Wang, Ai Ping ^b   Li, Lian Xi ^a   Li, Ting Ting ^a   Chen, Ming Yun ^a   Zhu, Yue ^a   Yu, Tian Pei ^a   Bao, Yu Qian ^a   Jia, Wei Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b No 454 Hospital of PLA   (China)

Author keywords

Alanine aminotransferase; Nonalcoholic fatty liver disease; Type 2 diabetes mellitus; Uric acid; Urine uric acid excretion

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; C PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIORITY JOURNAL; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINARY EXCRETION; URINE URIC ACID EXCRETION; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMPLICATION; RISK FACTOR; URINE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS; URIC ACID;

EID: 84965020601     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2016.04.017     Document Type: Article

References (41)

1. Baba, T., Amasaki, Y., Soda, M., Hida, A., Imaizumi, M., Ichimaru, S., et al. Fatty liver and uric acid levels predict incident coronary heart disease but not stroke among atomic bomb survivors in Nagasaki. Hypertension Research 30:9 (2007), 823–829.
2. Berk, P.D., Verna, E.C., Nonalcoholic fatty liver disease: Lipids and insulin resistance. Clinics in Liver Disease 20:2 (2016), 245–262.
3. Cardoso, A.S., Gonzaga, N.C., Medeiros, C.C., Carvalho, D.F., Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. Jornal de Pediatria 89:4 (2013), 412–418.
4. de Oliveira, E.P., Burini, R.C., High plasma uric acid concentration: Causes and consequences. Diabetology and Metabolic Syndrome, 4, 2012, 12.
5. Facchini, F., Chen, Y.D., Hollenbeck, C.B., Reaven, G.M., Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:21 (1991), 3008–3011.
6. Fan, J.G., Zhu, J., Li, X.J., Chen, L., Li, L., Dai, F., et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. Journal of Hepatology 43:3 (2005), 508–514.
7. Ferreira, V.S., Pernambuco, R.B., Lopes, E.P., Morais, C.N., Rodrigues, M.C., Arruda, M.J., et al. Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. Arquivos Brasileiros de Endocrinologia e Metabologia 54:4 (2010), 362–368.
8. Hou, X.H., Zhu, Y.X., Lu, H.J., Chen, H.F., Li, Q., Jiang, S., et al. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. Journal of Gastroenterology and Hepatology 26:4 (2011), 722–730.
9. Hu, X., Huang, Y., Bao, Z., Wang, Y., Shi, D., Liu, F., et al. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterology, 12, 2012, 123.
10. Hwang, I.C., Suh, S.Y., Suh, A.R., Ahn, H.Y., The relationship between normal serum uric acid and nonalcoholic fatty liver disease. Journal of Korean Medical Science 26:3 (2011), 386–391.
11. Lanaspa, M.A., Sanchez-Lozada, L.G., Choi, Y.J., Cicerchi, C., Kanbay, M., Roncal-Jimenez, C.A., et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: Potential role in fructose-dependent and -independent fatty liver. The Journal of Biological Chemistry 287:48 (2012), 40732–40744.
12. Li, L.X., Dong, X.H., Li, M.F., Zhang, R., Li, T.T., Shen, J., et al. Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. Journal of Hypertension 33:3 (2015), 482–490.
13. Li, L.X., Lu, J.X., Shuai, H.P., Xia, H.F., Zhang, R., Wang, J.W., et al. Decreased urine uric acid excretion is associated with diabetic retinopathy but not with lower limb atherosclerosis in hospitalized patients with type 2 diabetes. Atherosclerosis 242:1 (2015), 13–18.
14. Li, H., Wang, Y.J., Tan, K., Zeng, L., Liu, L., Liu, F.J., et al. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary & Pancreatic Diseases International 8:4 (2009), 377–382.
15. Li, L.X., Wang, A.P., Zhang, R., Li, T.T., Wang, J.W., Bao, Y.Q., et al. Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for carotid atherosclerosis in hospital-based patients with type 2 diabetes: A cross-sectional study. Cardiovascular Diabetology, 14, 2015, 36.
16. Li, L., Yu, H., Zhu, J., Wu, X., Liu, F., Zhang, F., et al. The combination of carotid and lower extremity ultrasonography increases the detection of atherosclerosis in type 2 diabetes patients. Journal of Diabetes and its Complications 26:1 (2012), 23–28.
17. Liang, J., Pei, Y., Gong, Y., Liu, X.K., Dou, L.J., Zou, C.Y., et al. Serum uric acid and non-alcoholic fatty liver disease in non-hypertensive Chinese adults: The Cardiometabolic Risk in Chinese (CRC) study. European Review for Medical and Pharmacological Sciences 19:2 (2015), 305–311.
18. Lu, H., Zeng, L., Liang, B., Shu, X., Xie, D., High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Archives of Medical Research 40:7 (2009), 571–575.
19. Lv, W.S., Sun, R.X., Gao, Y.Y., Wen, J.P., Pan, R.F., Li, L., et al. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes. World Journal of Gastroenterology 19:20 (2013), 3134–3142.
20. Noone, D.G., Marks, S.D., Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease. The Journal of Pediatrics 162:1 (2013), 128–132.
21. Omagari, K., Takamura, R., Matsutake, S., Ichimura, M., Kato, S., Morikawa, S., et al. Serum alanine aminotransferase concentration as a predictive factor for the development or regression of fatty liver. Journal of Clinical Biochemistry and Nutrition 49:3 (2011), 200–206.
22. Park, S.H., Kim, B.I., Yun, J.W., Kim, J.W., Park, D.I., Cho, Y.K., et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. Journal of Gastroenterology and Hepatology 19:6 (2004), 694–698.
23. Petta, S., Camma, C., Cabibi, D., Di, M.V., Craxi, A., Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 34:7 (2011), 757–766.
24. Ryu, S., Chang, Y., Kim, S.G., Cho, J., Guallar, E., Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism 60:6 (2011), 860–866.
25. Sertoglu, E., Ercin, C.N., Celebi, G., Gurel, H., Kayadibi, H., Genc, H., et al. The relationship of serum uric acid with non-alcoholic fatty liver disease. Clinical Biochemistry 47:6 (2014), 383–388.
26. Shih, M.H., Lazo, M., Liu, S.H., Bonekamp, S., Hernaez, R., Clark, J.M., Association between serum uric acid and nonalcoholic fatty liver disease in the US population. Journal of the Formosan Medical Association 114:4 (2015), 314–320.
27. Sirota, J.C., McFann, K., Targher, G., Johnson, R.J., Chonchol, M., Jalal, D.I., Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey. Metabolism 62:3 (2013), 392–399.
28. Utzschneider, K.M., Kahn, S.E., Review: The role of insulin resistance in nonalcoholic fatty liver disease. The Journal of Clinical Endocrinology and Metabolism 91:12 (2006), 4753–4761.
29. Wang, T., Bi, Y., Xu, M., Huang, Y., Xu, Y., Li, X., et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 40:1 (2011), 109–116.
30. Williamson, R.M., Price, J.F., Glancy, S., Perry, E., Nee, L.D., Hayes, P.C., et al. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Diabetes Care 34:5 (2011), 1139–1144.
31. Wu, S.J., Zhu, G.Q., Ye, B.Z., Kong, F.Q., Zheng, Z.X., Zou, H., et al. Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: A large population-based study. Medicine (Baltimore), 94(17), 2015.
32. Xia, M.F., Lin, H.D., Li, X.M., Yan, H.M., Bian, H., Chang, X.X., et al. Renal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middle-aged and elderly Chinese population. Clinical and Experimental Pharmacology & Physiology 39:11 (2012), 930–937.
33. Xie, Y., Wang, M., Zhang, Y., Zhang, S., Tan, A., Gao, Y., et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PLoS One, 8(7), 2013, e67152.
34. Xu, C., Yu, C., Ma, H., Xu, L., Miao, M., Li, Y., Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: The Zhejiang Zhenhai Study. The American Journal of Gastroenterology 108:8 (2013), 1299–1304.
35. Xu, C., Yu, C., Xu, L., Miao, M., Li, Y., High serum uric acid increases the risk for nonalcoholic fatty liver disease: A prospective observational study. PLoS One, 5(7), 2010, e11578.
36. Yajima, Y., Ohta, K., Narui, T., Abe, R., Suzuki, H., Ohtsuki, M., Ultrasonographical diagnosis of fatty liver: Significance of the liver-kidney contrast. The Tohoku Journal of Experimental Medicine 139:1 (1983), 43–50.
37. Yamada, T., Suzuki, S., Fukatsu, M., Wada, T., Yoshida, T., Joh, T., Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. Acta Gastroenterologica Belgica 73:1 (2010), 12–17.
38. Zelber-Sagi, S., Ben-Assuli, O., Rabinowich, L., Goldstein, A., Magid, A., Shalev, V., et al. The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort. Liver International 35:11 (2015), 2408–2415.
39. Zeng, M.D., Li, Y.M., Chen, C.W., Lu, L.G., Fan, J.G., Wang, B.Y., et al. Guidelines for the diagnosis and treatment of alcoholic liver disease. Journal of Digestive Diseases 9:2 (2008), 113–116.
40. Zhou, J., Jia, W.P., Bao, Y.Q., Ma, X.J., Lu, W., Yu, M., et al. Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes. Zhonghua Yi Xue Za Zhi 87:32 (2007), 2249–2252.
41. Zhou, Y.J., Li, Y.Y., Nie, Y.Q., Ma, J.X., Lu, L.G., Shi, S.L., et al. Prevalence of fatty liver disease and its risk factors in the population of South China. World Journal of Gastroenterology 13:47 (2007), 6419–6424.